• Myositis:
  • Infective myositis  
  • Tropical pyomyositis
  • Dermatopolymyositis 
  • Polymyositis 
  • Interstitial myositis 
• Calcification and ossification of muscle
  • Myositis ossificans traumatica
  • Myositis ossificans progressiva 
  • Fibrodysplasia ossificans progressiva
  • associated with quadriplegia or paraplegia
  • associated with burns 
• Paralytic calcification and ossification of muscle 
• Foreign body granuloma of soft tissue, not elsewhere classified 
• Disorders of myoneural junction and muscle in diseases classified elsewhere 
• EXCLUDES:
  • foreign body granuloma of skin and subcutaneous tissue, calcific tendinitis, tendinitis of shoulder
  •  Juvenile dermatomyositis  - excluded (Rheumatolgy referral)Glycogen storage disease: (Excluded – usually referred to Metabolic team)
  • Cardiac glycogenosis
  • Andersen
  • Cori
  • Forbes
  • Hers
  • McArdle
  • Pompe
  • Tauri
  • von Gierke
• Liver phosphorylase deficiency (Excluded – usually referred to Metabolic team)

• Mitochondrial myopathy

• Myotonic Dystrophy 1 (DM1)
• Myotonic Dystrophy 2 (DM2)
• Myotonia :
  • chondrodystrophic
  • drug-induced symptomatic
• Myotonia congenita:
  • dominant [Thomsen]
  • recessive [Becker]
  • Neuromyotonia [Isaacs]
  • Paramyotonia congenita
  • Pseudomyotonia

• Myasthenia gravis 
• Toxic myoneural disorders 
• Congenital myasthenia syndromes
• Other specified myoneural disorders 
•  Myasthenic syndromes in endocrine diseases
• Myasthenic syndromes in:
  • diabetic amyotrophy  
  • thyrotoxicosis [hyperthyroidism]
  • Eaton-Lambert syndrome
  • Other myasthenic syndromes in neoplastic disease
  • Myasthenic syndromes in other diseases classified elsewhere 

EXCLUDES:  botulism and transient neonatal myasthenia gravis.

• Spinal Muscular Atrophy (SMA) and related syndromes:
  • Infantile spinal muscular atrophy, type I [Werdnig-Hoffman] 
  • Other inherited spinal muscular atrophy
  • Progressive bulbar palsy of childhood [Fazio-Londe]
  • SMA adult form
  • SMA childhood form, type II
  • Distal SMA
  • SMA juvenile form, type III [Kugelberg-Welander]
  • SMA scapuloperoneal form
• Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere 
• Primary disorders of muscles 
• Paraneoplastic and neuropathy
  • Sensorial paraneoplastic neuropathy [Denny Brown] 
• Hereditary motor and sensory neuropathy
  • Charcot-Marie-Tooth
  • Déjerine-Sottas
  • Refsum's disease 
  • Hereditary motor and sensory neuropathy, types I-IV
  • Hypertrophic neuropathy of infancy
  • Peroneal muscular atrophy (axonal type) (hypertrophic type)
  • Roussy-Lévy syndrome
• Neuropathy in association with hereditary ataxia , such as Ataxia Telangectasia
• Idiopathic progressive neuropathy
• Inflammatory polyneuropathy
  • Guillain-Barré syndrome 
  • Acute (post-) infective polyneuritis
• Drug-induced/Alcoholic/Toxic Agent/Radiation induced polyneuropathy 
• Serum neuropathy 
• Polyneuropathy in infectious and parasitic diseases classified elsewhere:
  • diphtheria 
  • infectious mononucleosis         
  • leprosy
  • Lyme disease
  • mumps
  • postherpetic
  • syphilis, late
  • congenital syphilis, late
  • tuberculous
  • Diabetic polyneuropathy
• Polyneuropathy in:
  • other endocrine and metabolic diseases   
  • neoplastic disease
  •  nutritional deficiency
  • systemic connective tissue disorders
  • other musculoskeletal disorders
  • Uraemic neuropathy  

INCLUDES:  arthrogryposis multiplex congenita, metabolic myopathies

EXCLUDES: Dermatomyositis 

• Muscular dystrophy, including
  • autosomal recessive, childhood type
  • benign [Becker]
  • benign scapuloperoneal with early contractures [Emery-Dreifuss]
  • distal
  • facioscapulohumeral
  •  limb-girdle
  • ocular
  • oculopharyngeal
  • scapuloperoneal
  • Duchenne
• INCLUDES: congenital muscular dystrophy, congenital myopathy, including:
  • central core disease
  • minicore  disease
  • multicore disease
  • Fibre-type disproportion
  • myotubular (centronuclear)
  • nemaline
  • unspecified hereditary myopathy
• Drug-induced/Alcoholic/toxic agent/inflammatory myopathy 
• Myopathy in infectious/parasitic disease
• Myopathy in endocrine disease
  • hyperparathyroidism
  • hypoparathyroidism
  • Thyrotoxic myopathy
• Myopathy in metabolic disease
  • glycogen storage disease
  • lipid storage disorders  
• Periodic paralysis, including:
  • Periodic paralysis (familial)
  • hyperkalaemic  
  • hypokalaemic
  • myotonic
  • normokalaemic
• Myopathy in other diseases:
  • rheumatoid arthritis
  • scleroderma
  • sicca syndrome [Sjögren]
  • systemic lupus erythematosus
• Paraneoplastic neuromyopathy
  • Carcinomatous neuromyopathy

The South West Neuromuscular Operational Delivery Network (SWNODN) covers a particular definition set of neuromuscular conditions specified by NHS England. We have split these down into six main categories as listed below. 

• Mitochondrial diseases
• Muscular Dystrophies and Myopathies
• Myasthenias
• Myotonias
• Neuropathies
• Other/Unclassified

If you do not see your condition listed, please do call the Network office and we will see if we can support you in another way or redirect you to the most appropriate organisation. 

The network does not cover the following conditions as there are other organisations/charities that offer a great deal of support for these patients:

• Multiple sclerosis
• Motor Neurone Disease
• Parkinson’s Disease
• Cerebral Palsy

The South West Neuromuscular Operational Delivery Network (SWNODN) currently has a Network Manager, Natalie Smith, and Network Coordinator, Jo McTiernan, based at Southmead Hospital Bristol.

For any queries relating to the SWNODN please contact the Network Manager in the first instance on 0117 41 41185.

The South West Neuromuscular Operational Delivery Network (SWNODN) employs four Neuromuscular Advisors hosted by Southmead Hospital Bristol and Derriford Hospital Plymouth.  Their role is to be a key resource for children and adults who have a neuromuscular condition, and their families and carers.  Each Neuromuscular Advisor covers a region of the South West.   They attend the paediatric and adult neuromuscular clinics to meet with patients and provide additional information at the point of diagnosis.  They are also available to discuss issues over the phone or to visit patients and families at home if necessary. They can facilitate access to local help and support services as needed, to optimise independent living and patient self-management as much as possible. 

Find out more about the Neuromuscular Advisor's role: 

The South West Neuromuscular Operational Delivery Network (SWNODN) employs three Paediatric Neuromuscular Physiotherapists and three Adult Neuromuscular Physiotherapists.   The Neuromuscular Physiotherapists attend paediatric, transition and adult neuromuscular clinics around the region, providing specialist advice and support to patients, families and carers.  They are also a valuable resource for advising, supporting and training local teams in various aspects of the specific physiotherapy assessment and management of neuromuscular conditions.  Community Physiotherapists are always very welcome to attend specialist neuromuscular clinics along with their patients.  The Neuromuscular Physiotherapists will liaise with Community Physiotherapists about their patients as necessary, but especially before and after a clinic visit.

Our Neuromuscular Physiotherapists may attend home or school visits, as required, with a Neuromuscular Advisor and can offer ongoing advice and support to patients and their families to help them deal with the physical challenges of a neuromuscular condition.